Monitoring therapy success of urogenital Chlamydia trachomatis infections in women: A prospective observational cohort study.

Bart VersteegSylvia M BruistenTitia HeijmanWilma VermeulenMartijn S van RooijenAlje P van DamMaarten F Schim van der LoeffHenry J C de VriesMaarten Scholing

Published in: PloS one (2017)

Most RNA- or DNA-positive results after treatment of urogenital C. trachomatis may be caused by non-viable molecular remnants since they cannot be confirmed by culture. In a minority viable C. trachomatis was found in culture at the second visit, indicating that patients may remain infectious at least 7 days after treatment.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
single molecule
polycystic ovary syndrome
pregnant women
circulating tumor
nucleic acid
patient reported outcomes
metabolic syndrome
adipose tissue
bone marrow
pregnancy outcomes
cell therapy
circulating tumor cells
smoking cessation